The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study
Open accessAbstract
OBJECTIVES: Very few studies have investigated clinical features associated with treatment-resistant depression (TRD) defined as failure of at least 2 consecutive antidepressant trials. The primary objective of this multicenter study was to identify specific clinical and demographic factors associated with TRD in a large sample of patients with major depressive episodes that failed to reach response or remission after at least 2 consecutive adequate antidepressant treatments. METHOD: A total of 702 patients with DSM-IV major depressive disorder, recruited from January 2000 to February 2004, were included in the analysis. Among them, 346 patients were considered as nonresistant. The remaining 356 patients were considered as resistant, with a 17-item Hamilton Rating Scale for Depression score remaining greater than or equal to 17 after 2 consecutive adequate antidepressant trials. Cox regression models were used to examine the association between individual clinical variables and TRD. RESULTS: Among the clinical features investigated, 11 variables were found to be associated with TRD. We found anxiety comorbidity (p < .001, odds ratio [OR] = 2.6), comorbid panic disorder (p < .001, OR = 3.2) and social phobia (p = .008, OR = 2.1), personality disorder (p = .049, OR = 1.7), suicidal risk (p = .001, OR = 2.2), severity (p = .001, OR = 1.7), melancholia (p = .018, OR = 1.5), a number of hospitalizations > 1 (p = .003, OR = 1.6), recurrent episodes (p = .009, OR = 1.5), early age at onset (p = .009, OR = 2.0), and nonresponse to the first antidepressant received lifetime (p = .019, OR = 1.6) to be the factors associated with TRD. CONCLUSIONS: Our findings provide a set of 11 relevant clinical variables associated with treatment resistance in major depressive disorder that can be explored at the clinical level. The statistical model used in this analysis allowed for a hierarchy of these variables (based on the OR) showing that comorbid anxiety disorder is the most powerful clinical factor associated with TRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This comorbidity pattern may also affect treatment outcomes, with pharmacotherapy studies indicating that comorbid SAD is associated with a poorer course of illness (Mulder, Joyce, Frampton, Luty, & Sullivan, 2006), treatment-resistant depression (Souery et al., 2007), and a greater number and earlier onset of depressive recurrences compared with patients without comorbid SAD (Holma, Holma, Melart”
From An Integrated, Acceptance-Based Behavioral Approach for Depression With Social Anxiety: Preliminary Results (2014) · cites this paper as Souery et al., 2007
In the citing paper
“Prevalence estimates of TRS, TRD, and treatment resistant OCD vary from 20-60% of the population with the condition. 26, 35–40”
From Treatment resistance in psychiatry: state of the art and new directions (2022) · cites this paper as [39]
In the citing paper
“Timing may add heterogeneous features: certain individuals may change readily with respect to certain symptoms, whereas other subjects may have opposite tendencies [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
In the citing paper
“The basic flaw is to assume improvement to be a unitary phenomenon [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
In the citing paper
“Comorbidities such as substance use disorder can undermine previously effective maintenance therapy [18]”
In the citing paper
“Approximately only one in two patients with major depressive disorder (MDD) respond to their antidepressant treatment ( Rush et al., 2006 , Souery et al., 2007 , Thomas et al., 2013 )”
From Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder (2023) · cites this paper as Souery et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
Self-citationSheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
(1997) · PubMed · Cited by 727
Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Treatment resistant depression: methodological overview and operational criteria
Souery, D., Amsterdam, J. D., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, G., Zohar, J., & Mendlewicz, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00004-2 · Cited by 443
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- a Copyright Daniel Souery, M.D. early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004;55:875-881
Cited by
Sorted by citations
Items 101–200 of 526
Clinical Implications of Genetic Variation in the Serotonin Transporter Promoter Region
Luddington, N. S., Mandadapu, A., Husk, M., & El‐Mallakh, R. S. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00656 · Cited by 64
Takahashi, M., Shirayama, Y., Muneoka, K. T., Suzuki, M., Sato, K., & Hashimoto, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071964 · Cited by 64
Morag, A., Pasmanik, M., Oron‐Karni, V., Rehavi, M., Stingl, J., & Gurwitz, D. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.185 · Cited by 64
Prognosis and Improved Outcomes in Major Depression: A Review
Kraus, C., Kadriu, B., Lanzenberger, R. R., Zarate, C. A., & Kasper, S. F. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18205 · Cited by 64
Self-citationNie, Z., Vairavan, S., Narayan, V. A., Ye, J., & Li, Q. S. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197268 · Cited by 62
Leal, G. C., Souza-Marques, B., Mello, R. P., Bandeira, I. D., Caliman-Fontes, A. T., Carneiro, B. A., Faria-Guimarães, D., Guerreiro-Costa, L. N. F., Jesus-Nunes, A. P., Silva, S. S., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.151 · Cited by 62
The economics of psychedelic-assisted therapies: A research agenda
Marseille, E. A., Bertozzi, S., & Kahn, J. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1025726 · Cited by 62
Management of Treatment-Resistant Depression
Keitner, G. I., & Mansfield, A. K. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.004 · Cited by 62
The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
Fabbri, C., Corponi, F., Souery, D., Kasper, S. F., Montgomery, S., Zohar, J., Rujescu, D., Mendlewicz, J., & Serretti, A. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy024 · Cited by 62
Self-citationFabbri, C., Kasper, S., Kautzky, A., Bartova, L., Dold, M., Zohar, J., Souery, D., Montgomery, S., Albani, D., Raimondi, I., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.256 · Cited by 61
Self-citationAdapting Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
Eisendrath, S., Chartier, M., & McLane, M. (2011) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2010.05.004 · Cited by 60
Lai, C., & Wu, Y. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.022 · Cited by 60
Predictors of remission from generalized anxiety disorder and major depressive disorder
Kelly, K. M., & Mezuk, B. R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.042 · Cited by 60
The economic impact of depression: Resistance or severity?
Fostick, L., Silberman, A., Beckman, M., Спивак, Б., & Amital, D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.001 · Cited by 59
Katzelnick, D. J., Duffy, F. F., Chung, H., Regier, D. A., Rae, D. S., & Trivedi, M. H. (2011) · Psychiatric Services · doi:10.1176/ps.62.8.pss6208_0929 · Cited by 58
Porcelli, S., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P. P., Rujescu, D., Mendlewicz, J., Pich, E. M., Pollentier, S., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109835 · Cited by 57
Self-citationTreatment-Resistant Depression Increases Health Costs and Resource Utilization
Lepine, B. A., Moreno, R. A., Campos, R. N., & Couttolenc, B. F. (2012) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.05.009 · Cited by 57
Klein, J., Winter, C., Coquery, N., Heinz, A., Morgenstern, R., Kupsch, A. R., & Juckel, G. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.04.036 · Cited by 57
Kocabaş, N. A., Faghel, C., Barreto, M., Kasper, S. F., Linotte, S., Mendlewicz, J., Noro, M., Oswald, P., Souery, D., Zohar, J., et al. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338b884 · Cited by 55
Self-citationOved, K., Morag, A., Pasmanik-Chor, M., Oron-Karni, V., Shomron, N., Rehavi, M., Stingl, J. C., & Gurwitz, D. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.93 · Cited by 66
Kent, J. M., Daly, E., Kezic, I., Lane, R., Lim, P., De Smedt, H., De Boer, P., Van Nueten, L., Drevets, W. C., & Ceusters, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.009 · Cited by 53
Combining machine learning algorithms for prediction of antidepressant treatment response
Kautzky, A., Möller, H., Dold, M., Bartova, L., Seemüller, F., Laux, G., Riedel, M. J., Gäebel, W., & Kasper, S. F. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13250 · Cited by 53
Self-citationTreatment-resistant depression: recent developments and future directions
Mathew, S. J. (2008) · Depression and Anxiety · doi:10.1002/da.20540 · Cited by 52
Lai, C., & Wu, Y. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000947 · Cited by 52
Salloum, N. C., D, M. F. M., Freeman, M. P., Flynn, M., Hoeppner, B. B., Hock, R. S., Cusin, C., Iosifescu, D. V., Trivedi, M. H., Sanacora, G., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22875 · Cited by 52
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. Ν., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0259-6 · Cited by 51
Self-citationGeneral Predictors and Moderators of Depression Remission: A VAST-D Report
Zisook, S., Johnson, G. R., Tal, I., Hicks, P. B., Chen, P., Davis, L. L., Thase, M., Zhao, Y., Vertrees, J. E., & Mohamed, S. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18091079 · Cited by 51
Temperament and character influence on depression treatment outcome
Balestri, M., Porcelli, S., Souery, D., Kasper, S. F., Dikeos, D. G., Ferentinos, P. P., Papadimitriou, G. N., Rujescu, D., Martinotti, G., Nicola, M. D., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.031 · Cited by 51
Self-citationFanelli, G., Domschke, K., Minelli, A., Gennarelli, M., Martini, P. G. V., Bortolomasi, M., Maron, E., Squassina, A., Kasper, S., Zohar, J., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.11.005 · Cited by 51
Self-citationMatsunaga, M., Okamoto, Y., Suzuki, S.-I., Kinoshita, A., Yoshimura, S., Yoshino, A., Kunisato, Y., & Yamawaki, S. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-22 · Cited by 50
Hamilton, J. P., Chen, M. C., Waugh, C. E., Joormann, J., & Gotlib, I. H. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsu084 · Cited by 50
Fabbri, C., Kasper, S., Kautzky, A., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P. P., Rujescu, D., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0738-5 · Cited by 50
Self-citationSerretti, A., Chiesa, A., Calati, R., Massat, I., Linotte, S., Kasper, S. F., Lecrubier, Y., Antonijevic, I. A., Forray, C., & Snyder, L. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.025 · Cited by 49
Self-citationOlgiati, P., Serretti, A., Souery, D., Dold, M., Kasper, S. F., Montgomery, S., Zohar, J., & Mendlewicz, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.004 · Cited by 49
Self-citationThe Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem
Fava, G. A., Cosci, F., Guidi, J., & Rafanelli, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000507227 · Cited by 48
Serretti, A., Chiesa, A., Calati, R., Perna, G., Bellodi, L., & Ronchi, D. D. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32831db2d7 · Cited by 48
Self-citationSouery, D., Serretti, A., Calati, R., Oswald, P., Massat, I., Konstantinidis, A., Linotte, S., Kasper, S. F., Montgomery, S., Zohar, J., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.590225 · Cited by 48
Self-citationFabbri, C., Corponi, F., Albani, D., Raimondi, I., Forloni, G., Schruers, K. R. J., Kasper, S. F., Kautzky, A., Zohar, J., Souery, D., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.005 · Cited by 48
Self-citationAmitai, M., Kronenberg, S., Carmel, M., Michaelovsky, E., Frisch, A., Brent, D. A., Apter, A. S., Chen, A., Weizman, A., & Fennig, S. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1585-7 · Cited by 47
Daly, E., Turkoz, I., Salvadore, G., Fedgchin, M. M., Ionescu, D. F., Starr, H. L., Borentain, S., Trivedi, M. H., Thase, M. E., & Singh, J. B. (2021) · Depression and Anxiety · doi:10.1002/da.23193 · Cited by 47
Zaninotto, L., Souery, D., Calati, R., Nicola, M. D., Montgomery, S., Kasper, S. F., Zohar, J., Mendlewicz, J., Cloninger, C. R., Serretti, A., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.036 · Cited by 47
Self-citation5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Noro, M., Antonijevic, I. A., Forray, C., Kasper, S. F., Kocabaş, N. A., Lecrubier, Y., Linotte, S., Mendlewicz, J., Montgomery, S., Snyder, L., et al. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338bcf4 · Cited by 47
Self-citationSchosser, A., Calati, R., Serretti, A., Massat, I., Kocabaş, N. A., Papageorgiou, K., Linotte, S., Mendlewicz, J., Souery, D., Zohar, J., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.007 · Cited by 47
Self-citationAntipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
Sultan, R. S., Wang, S., Crystal, S., & Olfson, M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7850 · Cited by 47
Kim, N., Cho, S., Kim, H.-Y., Kim, S. H., Lee, H. J., Park, C. H. K., Rhee, S. J., Kim, D.-W., Yang, B. R., Choi, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221552 · Cited by 46
Lai, C. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.086 · Cited by 46
Yang, C., Zhang, X., Liu, Y., Du, J., Liang, R., Yu, M., Zhang, F. Q., Mu, X., Li, F., Zhou, L., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00101-2 · Cited by 46
Serotonin transporter gene polymorphisms and treatment-resistant depression
Bonvicini, C., Minelli, A., Scassellati, C., Bortolomasi, M., Segala, M., Sartori, R., Giacopuzzi, M., & Gennarelli, M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.020 · Cited by 46
Calati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.005 · Cited by 45
Self-citationNygren, A., Reutfors, J., Brandt, L., Bodén, R., Nordenskjöld, A., & Tiger, M. (2023) · BJPsych Open · doi:10.1192/bjo.2023.5 · Cited by 45
Kraus, C., Kautzky, A., Watzal, V., Gramser, A., Kadriu, B., Deng, Z., Bartova, L., Zarate, C. A., Lanzenberger, R. R., Souery, D., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.042 · Cited by 45
Self-citationGao, K., Wang, Z., Chen, J., Kemp, D. E., Chan, P. K., Conroy, C. M., Serrano, M. B., Ganocy, S. J., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.004 · Cited by 45
Dinh, K. T., Yang, D. D., Nead, K. T., Reznor, G., Trinh, Q., & Nguyen, P. L. (2017) · International Journal of Urology · doi:10.1111/iju.13409 · Cited by 45
The antidepressant impact of minocycline in rodents: A systematic review and meta-analysis
Reis, D. J., Casteen, E. J., & Ilardi, S. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-36507-9 · Cited by 45
Huang, S., Chen, H.-H., Wang, J., Chen, W. J., Chen, H., & Kuo, P. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02935-z · Cited by 45
Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
Moderie, C., Núñez, N. A., Fielding, A., Comai, S., & Gobbi, G. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac017 · Cited by 44
Eisendrath, S. J., Gillung, E. P., Delucchi, K. L., Chartier, M., Mathalon, D. H., Sullivan, J. C., Segal, Z. V., & Feldman, M. D. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-95 · Cited by 43
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
de Sousa, R. T., V. Zanetti, M., R. Brunoni, A., & Machado-Vieira, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630173522 · Cited by 43
Antidepressant use in low- middle- and high-income countries: a World Mental Health Surveys report
Kazdin, A. E., Wu, C., Hwang, I. H., Puac‐Polanco, V., Sampson, N. A., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Benjet, C. L., Caldas-de-Almeida, J. M., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721003160 · Cited by 43
Efficacy of Deep TMS with the H1 Coil for Anxious Depression
Pell, G. S., Harmelech, T., Zibman, S., Roth, Y., Tendler, A., & Zangen, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041015 · Cited by 43
Brenner, P., Brandt, L., Li, G., DiBernardo, A., Bodén, R., & Reutfors, J. (2019) · Addiction · doi:10.1111/add.14866 · Cited by 43
Papakostas, G. I., & Larsen, K. G. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0149-3 · Cited by 43
Papakostas, G. I., Fan, H., & Tedeschini, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.009 · Cited by 43
Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 44
MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression
Lee, S. H., Lee, M., Lee, J. H., Kim, S. W., Kang, R.-H., Choi, M.-J., Park, S. J., Kim, S. J., Lee, J. M., Cole, S. P. C., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d2ef42 · Cited by 42
Gudayol‐Ferré, E., Herrera‐Guzmán, I., Camarena, B., Cortés‐Penagos, C., Herrera‐Abarca, J. E., Martínez‐Medina, P., la Cruz, D. C.-D., Hernández, S., Genis, A. D., Carrillo-Guerrero, M. Y., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.002 · Cited by 42
Mothers with Depression, School-Age Children with Depression? A Systematic Review
Mendes, A. V., Loureiro, S. R., Crippa, J. A. S., Gaya, C. D. M., García-Esteve, L., & Martín‐Santos, R. (2011) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2011.00318.x · Cited by 41
Forand, N. R., & DeRubeis, R. J. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0032985 · Cited by 41
Fabbri, C., Marsano, A., Albani, D., Chierchia, A., Calati, R., Drago, A., Crisafulli, C., Calabrò, M., Kasper, S. F., Lanzenberger, R. R., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.15 · Cited by 41
Self-citationBipolar II disorder as a risk factor for postpartum depression
Mandelli, L., Souery, D., Bartova, L., Kasper, S. F., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.025 · Cited by 41
Self-citationMetacognitive Therapy in Major Depression: An Open Trial of Comorbid Cases
Hjemdal, O., Hagen, R., Solem, S., Nordahl, H., Kennair, L. E. O., Ryum, T., Nordahl, H. M., & Adrian Wells, A. (2016) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2016.06.006 · Cited by 41
van Noorden, M. S., van Fenema, E. M., van der Wee, N. J. A., Zitman, F. G., & Giltay, E. J. (2012) · Depression and Anxiety · doi:10.1002/da.21958 · Cited by 40
Vincenzo, M. D., Martiadis, V., Rocca, B. D., Arsenio, E., D’Arpa, A., Volpicelli, A., Luciano, M., Sampogna, G., & Fiorillo, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1394787 · Cited by 39
Why Do You Need to Move Beyond First-Line Therapy for Major Depression?
Culpepper, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9104su1c.01 · Cited by 39
Bouaziz, N., Laidi, C., Bulteau, S., Berjamin, C., Thomas, F., Moulier, V., Benadhira, R., Székely, D. L., Poulet, E., Galvão, F., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.070 · Cited by 39
Bobo, W. V., Ommeren, B. V., & Athreya, A. P. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2112949 · Cited by 39
Asp, M., Lindqvist, D., Fernström, J., Ambrus, L., Tuninger, E., Reis, M., & Westrin, Å. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227364 · Cited by 38
Social inequalities in antidepressant treatment outcomes: a systematic review
Elwadhi, D., & Cohen, A. (2020) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-020-01918-5 · Cited by 38
Neuronal cell adhesion genes and antidepressant response in three independent samples
Fabbri, C., Crisafulli, C., Gurwitz, D., Stingl, J., Calati, R., Albani, D., Forloni, G., Calabrò, M., Martines, R., Kasper, S. F., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.15 · Cited by 37
Self-citationHennings, J. M., Kohli, M. A., Uhr, M., Holsboer, F., Ising, M., & Lucae, S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109686 · Cited by 37
COMT and age at onset in mood disorders: A replication and extension study
Massat, I., Kocabaş, N. A., Crisafulli, C., Chiesa, A., Calati, R., Linotte, S., Kasper, S. F., Fink, M., Antonijevic, I. A., Forray, C., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.012 · Cited by 36
Self-citationAmital, D., Fostick, L., Silberman, A., Calati, R., Spindelegger, C., Serretti, A., Juven‐Wetzler, A., Souery, D., Mendlewicz, J., Montgomery, S., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.002 · Cited by 36
Self-citationPhenomenology of psychotic mood disorders: Lifetime and major depressive episode features
Souery, D., Zaninotto, L., Calati, R., Linotte, S., Sentissi, O., Amital, D., Moser, U., Kasper, S. F., Zohar, J., Mendlewicz, J., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.027 · Cited by 35
Self-citationGuthrie, S., Bienkowska-Gibbs, T., Manville, C. M., Pollitt, A., Kirtley, A., & Wooding, S. (2015) · Health Technology Assessment · doi:10.3310/hta19670 · Cited by 34
Serretti, A., Chiesa, A., Calati, R., Linotte, S., Sentissi, O., Papageorgiou, K., Kasper, S. F., Zohar, J., Ronchi, D. D., Mendlewicz, J., et al. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0322-y · Cited by 34
Self-citationRapid acting antidepressants in the mTOR pathway: Current evidence
Athira, K. V., Mohan, A. S., & Chakravarty, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.022 · Cited by 34
Šagud, M., Mihaljević-Peleš, A., Uzun, S., Ćusa, B. V., Kozumplik, O., Mikulić, S. K., Mustapić, M., Barišić, I., Mück‐Šeler, D., & Pivac, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3085-x · Cited by 34
Toda, H., Tsunoda, T., Tanichi, M., Tanaka, T., Hashimoto, N., Nakato, Y., Nakagawa, S., Kitaichi, Y., Mitsui, N., Boku, S., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82236 · Cited by 34
Pawlowski, M. A., Gazea, M., Wollweber, B., Dresler, M., Holsboer, F., Keck, M. E., Steiger, A., Adamczyk, M., & Mikoteit, T. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.026 · Cited by 34
Terao, I., Tsuge, T., Endo, K., & Kodama, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.11.023 · Cited by 33
Treatment‐Resistant Depression and Risk of Suicide
Pfeiffer, P. N., Kim, H. M., Ganoczy, D. A., Zivin, K., & Valenstein, M. M. (2013) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12022 · Cited by 33
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Fukuyama, K., Motomura, E., & Okada, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032070 · Cited by 33
Enríquez-Castillo, A., Alamilla, J., Barral, J. A., Gourbière, S., Flores-Serrano, A. G., Góngora-Alfaro, J. L., & Pineda, J. C. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.03.004 · Cited by 33
Inoue, T., Kimura, T., Inagaki, Y., & Shirakawa, O. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s246294 · Cited by 32
Hägg, D., Brenner, P., Reutfors, J., Li, G., DiBernardo, A., Bodén, R., & Brandt, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236434 · Cited by 31
Baldinger, P., Gryglewski, G., Philippe, C., James, G. M., Vraka, C., Silberbauer, L., Balber, T., Vanicek, T., Pichler, V., Unterholzner, J., et al. (2019) · Brain stimulation · doi:10.1016/j.brs.2018.12.976 · Cited by 31
Self-citationMadsen, K. B., Plana‐Ripoll, O., Musliner, K. L., Debost, J.-C., Petersen, L. V., & Munk‐Olsen, T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.042 · Cited by 30
Mendlewicz, J., Massat, I., Linotte, S., Kasper, S. F., Konstantinidis, A., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., & Souery, D. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833c4ceb · Cited by 30
Self-citationSaraga, M., Gholam‐Rezaee, M., & Preisig, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.001 · Cited by 30
Hauksson, P., Ingibergsdóttir, S., Gunnarsdóttir, T., & Jónsdóttir, I. H. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1331263 · Cited by 29
Metadata
- Authors
- Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Mendlewicz, J., & Group for the Study of Resistant Depression (GSRD)
- Affiliations
- Université Libre de Bruxelles (BE)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-07-15
- Volume
- 68
- Issue
- 07
- Pages
- 1062-1070
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1969010498
- Cited by
- 521
- References
- 22
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 26 · 2023: 30 · 2022: 26 · 2021: 54 · 2020: 35 · 2019: 46 · 2018: 31 · 2017: 22 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 29 · 2012: 21
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Les Laboratories Pierre Fabre
- Fonds De La Recherche Scientifique - FNRS
- Servier
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, major depressive disorder, antidepressant non-response, anxiety comorbidity, panic disorder, social anxiety disorder, personality disorders, suicide risk, melancholia, depression severity, hospitalization, recurrent depression, age of onset, risk factors
- MeSH terms
- Adult, Aged, Antidepressive Agents, Mental Disorders, Major Depressive Disorder, Drug Resistance, Europe, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Recurrence, Comorbidity, Treatment Failure, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
